Lilly Stock Heading $1,000? What Investors Should Know
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Explore effective methods to manage surprise expenses within budgeting. Reallocate funds smartly and keep your financial plan intact.
16,044 articlesInvestors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Trump Media posted a $405.9 million quarterly loss in Q1 2026, largely tied to unrealized cryptocurrency holdings, ev...
Saudi Aramco posts a 25% year-over-year rise in quarterly profit, supported by higher exports via the East-West Pipel...
Dream Finders' unsolicited cash offer values Beazer at about $704 million, sparking a public contest as U.S. homebuil...
Palantir has wowed investors with AI-enabled results, but its sky-high valuation raises questions. This guide uses hi...
Stocks rally as AI names lead gains, but one gauge shows extraordinary greed. Investors weigh Buffett's caution again...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
Open Society Foundations committing $30 million over three years to support interfaith partnerships and protect commu...
The AI boom isn’t just about memory chips anymore. A broader wave of demand is lifting compute, software, and data in...
Rocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
A startup unveils a proprietary lithium extraction process that dramatically shortens timelines and boosts recovery, ...
Nvidia shares jumped after U.S. officials cleared exports of advanced AI processors to Chinese firms, sparking a rall...